Expression of PIK3IP1 in glioma - The Human Protein Atlas

GLIOBLASTOMA MULTIFORME (TCGA) - Interactive survival scatter plotⁱ

The Survival Scatter plot shows the clinical status (i.e. dead or alive) for all individuals in the patient cohort, based on the same data that underlies the corresponding Kaplan-Meier plots. Patients that are alive at last time for follow-up are shown in blue and patients who have died during the study are shown in red.

The x-axis shows the expression levels (FPKM) of the investigated gene in the tumor tissue at the time of diagnosis. The y-axis shows the follow-up time after diagnosis (years). Both axes are complimented with kernel density curves demonstrating the data density over the axes. The top density plot shows the expression levels (FPKM) distribution among dead (red) and alive patients (blue). The right density plot shows the data density of the survived years of dead patients with high and low expression levels respectively, stratified using the cutoff indicated by the vertical dashed line through the Survival Scatter plot. This cutoff is automatically defined based on the FPKM cutoff that minimizes the p-score. The cutoff can be changed by dragging the vertical line or by entering a cutoff value in the square labeled "Current cut-off".

Under the Survival Scatter plot the p-score landscape (black curve; left axis) is shown together with dead median separation (red curve; right axis). Dead median separation is the difference in median mRNA expression between patients who have died with high and low expression, respectively. It is calculated as follows: median FPKM expression of dead patients with high expression - median FPKM expression of dead patients with low expression. This is intended to aid the user in visually exploring custom cutoffs and the associated p-scores and dead median separation.

Individual patient data is displayed and can be filtered by clicking on one or more of the category buttons on the top of the page. Categories describing expression level and patient information include: high, low, alive, dead, female, male and tumor stages. The scale of the x-axis can be toggled between linear and log-scale by clicking on the "x log" button. Mouse-over function shows TCGA ID, patient information and mRNA expression (FPKM) for each patient.

& Survival analysisⁱ

PIK3IP1 is not prognostic in Glioblastoma Multiforme (TCGA)

Stage:

Survival analysis

Current cut offⁱ :

Best expression cut offⁱ : 14.85

Median expressionⁱ : N/A

Median follow up timeⁱ : N/A

P scoreⁱ N/A

3-year survival highⁱ N/A

3-year survival lowⁱ N/A

TCGA RNA samplesⁱ

Average TPM

24.4

Number of samples

141

Samples

Sample	Description	TPM
TCGA-06-5859-01A	0 years, male, white, stage:'--, alive, 139 days	115.0
TCGA-06-5410-01A	0 years, female, white, stage:'--, dead, 108 days	72.4
TCGA-06-0184-01A	0 years, male, white, stage:'--, dead, 2126 days	65.7
TCGA-06-0139-01A	0 years, male, white, stage:'--, dead, 362 days	63.7
TCGA-15-1444-01A	0 years, male, white, stage:'--, dead, 1537 days	52.5
TCGA-76-4929-01A	0 years, female, white, stage:'--, dead, 111 days	48.6
TCGA-28-5207-01A	0 years, male, white, stage:'--, dead, 343 days	48.0
TCGA-06-0132-01A	0 years, male, white, stage:'--, dead, 771 days	43.8
TCGA-32-1982-01A	0 years, female, white, stage:'--, dead, 142 days	43.5
TCGA-32-1980-01A	0 years, male, white, stage:'--, dead, 36 days	43.3
TCGA-28-2513-01A	0 years, female, white, stage:'--, alive, 222 days	42.9
TCGA-02-0047-01A	0 years, male, white, stage:'--, dead, 448 days	38.9
TCGA-06-0882-01A	0 years, male, white, stage:'--, dead, 632 days	38.8
TCGA-27-2521-01A	0 years, male, white, stage:'--, dead, 510 days	38.4
TCGA-06-2557-01A	0 years, male, black or african american, stage:'--, dead, 33 days	38.4
TCGA-06-0141-01A	0 years, male, white, stage:'--, dead, 313 days	38.2
TCGA-06-0190-01A	0 years, male, white, stage:'--, dead, 317 days	38.0
TCGA-16-0846-01A	0 years, male, white, stage:'--, dead, 119 days	37.6
TCGA-06-0129-01A	0 years, male, asian, stage:'--, dead, 1024 days	37.3
TCGA-06-0749-01A	0 years, male, black or african american, stage:'--, dead, 82 days	36.2
TCGA-06-2567-01A	0 years, male, white, stage:'--, dead, 133 days	35.8
TCGA-06-5411-01A	0 years, male, white, stage:'--, dead, 254 days	35.4
TCGA-02-2486-01A	0 years, male, white, stage:'--, dead, 618 days	34.9
TCGA-06-0138-01A	0 years, male, white, stage:'--, dead, 737 days	34.8
TCGA-28-1753-01A	0 years, male, white, stage:'--, alive, 37 days	34.5
TCGA-19-2629-01A	0 years, male, white, stage:'--, dead, 737 days	34.3
TCGA-28-5220-01A	0 years, male, white, stage:'--, dead, 388 days	34.2
TCGA-12-5295-01A	0 years, female, white, stage:'--, dead, 454 days	33.8
TCGA-06-5412-01A	0 years, female, white, stage:'--, dead, 138 days	33.4
TCGA-26-1442-01A	0 years, male, white, stage:'--, alive, 953 days	33.3
TCGA-41-5651-01A	0 years, female, black or african american, stage:'--, dead, 460 days	33.3
TCGA-41-3915-01A	0 years, male, white, stage:'--, dead, 360 days	32.8
TCGA-41-4097-01A	0 years, female, white, stage:'--, dead, 6 days	32.6
TCGA-32-2632-01A	0 years, male, white, stage:'--, dead, 269 days	30.7
TCGA-32-2616-01A	0 years, female, white, stage:'--, dead, 224 days	29.8
TCGA-12-3650-01A	0 years, male, white, stage:'--, dead, 333 days	28.9
TCGA-06-2570-01A	0 years, female, white, stage:'--, alive, 958 days	28.8
TCGA-06-5414-01A	0 years, male, white, stage:'--, alive, 273 days	28.7
TCGA-06-0645-01A	0 years, female, white, stage:'--, dead, 175 days	28.6
TCGA-28-5215-01A	0 years, female, white, stage:'--, dead, 335 days	28.0
TCGA-06-0686-01A	0 years, male, white, stage:'--, dead, 432 days	27.8
TCGA-19-2619-01A	0 years, female, black or african american, stage:'--, alive, 294 days	27.4
TCGA-12-0619-01A	0 years, male, white, stage:'--, dead, 1062 days	27.2
TCGA-19-2620-01A	0 years, male, white, stage:'--, dead, 148 days	27.1
TCGA-06-5858-01A	0 years, female, white, stage:'--, alive, 187 days	26.9
TCGA-14-1823-01A	0 years, female, white, stage:'--, dead, 543 days	26.8
TCGA-19-1390-01A	0 years, female, white, stage:'--, dead, 772 days	26.7
TCGA-12-0618-01A	0 years, male, white, stage:'--, dead, 395 days	26.3
TCGA-06-0158-01A	0 years, male, white, stage:'--, dead, 329 days	26.2
TCGA-06-0157-01A	0 years, female, white, stage:'--, dead, 97 days	25.7
TCGA-06-2561-01A	0 years, female, white, stage:'--, dead, 537 days	25.3
TCGA-06-2559-01A	0 years, male, white, stage:'--, dead, 150 days	24.9
TCGA-06-0187-01A	0 years, male, white, stage:'--, dead, 828 days	24.6
TCGA-06-0178-01A	0 years, male, white, stage:'--, dead, 2681 days	24.5
TCGA-28-2514-01A	0 years, male, asian, stage:'--, alive, 160 days	24.2
TCGA-14-1825-01A	0 years, male, white, stage:'--, dead, 232 days	24.0
TCGA-02-0055-01A	0 years, female, white, stage:'--, dead, 76 days	24.0
TCGA-14-1829-01A	0 years, male, black or african american, stage:'--, alive, 218 days	23.8
TCGA-32-5222-01A	0 years, male, white, stage:'--, dead, 585 days	23.8
TCGA-06-2564-01A	0 years, male, white, stage:'--, alive, 181 days	23.7
TCGA-06-0211-01A	0 years, male, white, stage:'--, dead, 360 days	23.5
TCGA-32-1970-01A	0 years, male, white, stage:'--, dead, 468 days	23.5
TCGA-06-0168-01A	0 years, female, white, stage:'--, dead, 598 days	23.4
TCGA-06-0238-01A	0 years, male, white, stage:'--, dead, 405 days	23.1
TCGA-06-5417-01A	0 years, female, white, stage:'--, alive, 155 days	22.9
TCGA-06-5413-01A	0 years, male, white, stage:'--, alive, 268 days	22.8
TCGA-76-4932-01A	0 years, female, white, stage:'--, dead, 1458 days	22.7
TCGA-02-2483-01A	0 years, male, asian, stage:'--, alive, 466 days	22.4
TCGA-12-0616-01A	0 years, female, white, stage:'--, dead, 448 days	22.2
TCGA-06-0156-01A	0 years, male, white, stage:'--, dead, 178 days	21.9
TCGA-14-0789-01A	0 years, male, white, stage:'--, dead, 342 days	21.7
TCGA-76-4927-01A	0 years, male, white, stage:'--, dead, 535 days	21.6
TCGA-27-2528-01A	0 years, male, white, stage:'--, dead, 480 days	21.6
TCGA-28-5204-01A	0 years, male, white, stage:'--, dead, 454 days	21.0
TCGA-14-2554-01A	0 years, female, white, stage:'--, dead, 532 days	20.9
TCGA-06-0130-01A	0 years, male, white, stage:'--, dead, 394 days	20.9
TCGA-06-0210-01A	0 years, female, white, stage:'--, dead, 225 days	20.8
TCGA-14-0817-01A	0 years, female, white, stage:'--, dead, 164 days	20.8
TCGA-26-5139-01A	0 years, female, white, stage:'--, alive, 48 days	20.2
TCGA-32-2638-01A	0 years, male, white, stage:'--, dead, 766 days	20.0
TCGA-41-2571-01A	0 years, male, white, stage:'--, dead, 26 days	19.9
TCGA-06-2565-01A	0 years, male, asian, stage:'--, dead, 506 days	19.3
TCGA-06-0174-01A	0 years, male, white, stage:'--, dead, 98 days	19.1
TCGA-19-5960-01A	0 years, male, white, stage:'--, dead, 455 days	18.9
TCGA-14-1034-01A	0 years, female, stage:'--, dead, 485 days	18.9
TCGA-19-4065-01A	0 years, male, white, stage:'--, alive, 214 days	18.8
TCGA-27-2526-01A	0 years, female, white, stage:'--, dead, 87 days	18.6
TCGA-06-0878-01A	0 years, male, white, stage:'--, alive, 218 days	18.6
TCGA-12-5299-01A	0 years, female, white, stage:'--, dead, 98 days	18.5
TCGA-06-2558-01A	0 years, female, white, stage:'--, dead, 380 days	18.0
TCGA-12-3653-01A	0 years, female, white, stage:'--, dead, 442 days	17.7
TCGA-27-1830-01A	0 years, male, white, stage:'--, dead, 154 days	17.5
TCGA-26-5132-01A	0 years, male, white, stage:'--, alive, 286 days	17.5
TCGA-28-5218-01A	0 years, male, white, stage:'--, dead, 157 days	17.2
TCGA-06-2569-01A	0 years, female, black or african american, stage:'--, alive, 13 days	17.1
TCGA-06-0646-01A	0 years, male, white, stage:'--, dead, 175 days	17.1
TCGA-06-0219-01A	0 years, male, white, stage:'--, dead, 22 days	17.0
TCGA-27-1834-01A	0 years, male, white, stage:'--, dead, 1233 days	16.6
TCGA-32-2615-01A	0 years, male, white, stage:'--, dead, 485 days	16.6
TCGA-06-5418-01A	0 years, female, white, stage:'--, dead, 83 days	16.2
TCGA-28-5208-01A	0 years, male, white, stage:'--, dead, 544 days	16.0
TCGA-76-4931-01A	0 years, female, white, stage:'--, dead, 279 days	15.4
TCGA-26-5135-01A	0 years, female, white, stage:'--, dead, 270 days	15.3
TCGA-06-0747-01A	0 years, male, white, stage:'--, dead, 82 days	15.2
TCGA-27-2519-01A	0 years, male, white, stage:'--, dead, 550 days	15.2
TCGA-06-5856-01A	0 years, male, white, stage:'--, dead, 114 days	15.1
TCGA-14-0787-01A	0 years, male, asian, stage:'--, dead, 68 days	15.1
TCGA-27-1832-01A	0 years, female, white, stage:'--, dead, 300 days	15.0
TCGA-19-2624-01A	0 years, male, white, stage:'--, dead, 5 days	14.9
TCGA-06-0745-01A	0 years, male, white, stage:'--, dead, 239 days	14.9
TCGA-32-2634-01A	0 years, male, white, stage:'--, alive, 693 days	14.8
TCGA-27-1831-01A	0 years, male, white, stage:'--, dead, 505 days	14.5
TCGA-06-1804-01A	0 years, female, white, stage:'--, dead, 414 days	14.5
TCGA-27-1837-01A	0 years, male, white, stage:'--, dead, 427 days	14.4
TCGA-08-0386-01A	0 years, male, white, stage:'--, dead, 548 days	14.2
TCGA-06-0750-01A	0 years, male, white, stage:'--, dead, 28 days	14.2
TCGA-02-2485-01A	0 years, male, black or african american, stage:'--, alive, 470 days	14.2
TCGA-06-5408-01A	0 years, female, white, stage:'--, dead, 357 days	14.1
TCGA-76-4925-01A	0 years, male, white, stage:'--, dead, 146 days	13.8
TCGA-06-0125-01A	0 years, female, white, stage:'--, dead, 1448 days	13.6
TCGA-41-2572-01A	0 years, male, white, stage:'--, dead, 406 days	13.6
TCGA-12-0821-01A	0 years, male, white, stage:'--, dead, 323 days	13.6
TCGA-32-4213-01A	0 years, female, white, stage:'--, alive, 604 days	13.6
TCGA-28-2509-01A	0 years, female, white, stage:'--, alive, 145 days	13.4
TCGA-06-0644-01A	0 years, male, black or african american, stage:'--, dead, 384 days	13.3
TCGA-06-2563-01A	0 years, female, white, stage:'--, alive, 932 days	13.1
TCGA-28-5216-01A	0 years, male, white, stage:'--, alive, 415 days	13.0
TCGA-06-2562-01A	0 years, male, white, stage:'--, dead, 382 days	12.3
TCGA-26-5133-01A	0 years, male, white, stage:'--, alive, 452 days	11.9
TCGA-12-3652-01A	0 years, male, white, stage:'--, dead, 1062 days	11.2
TCGA-06-0743-01A	0 years, male, white, stage:'--, dead, 803 days	10.0
TCGA-27-1835-01A	0 years, female, white, stage:'--, dead, 648 days	10.0
TCGA-28-5209-01A	0 years, female, white, stage:'--, alive, 442 days	9.5
TCGA-06-5416-01A	0 years, female, white, stage:'--, alive, 204 days	8.8
TCGA-06-0744-01A	0 years, male, white, stage:'--, dead, 1426 days	8.4
TCGA-27-2524-01A	0 years, male, white, stage:'--, dead, 231 days	8.1
TCGA-27-2523-01A	0 years, male, white, stage:'--, dead, 489 days	7.8
TCGA-19-2625-01A	0 years, female, white, stage:'--, dead, 124 days	7.4
TCGA-15-0742-01A	0 years, male, white, stage:'--, dead, 419 days	6.6
TCGA-26-5134-01A	0 years, male, white, stage:'--, alive, 167 days	4.9
TCGA-14-0871-01A	0 years, female, white, stage:'--, dead, 880 days	2.5
Show allShow less

GLIOBLASTOMA MULTIFORME (VALIDATION) - Interactive survival scatter plotⁱ

& Survival analysisⁱ

PIK3IP1 is not prognostic in Glioblastoma Multiforme (validation)

Stage:

Survival analysis

Current cut offⁱ :

Best expression cut offⁱ : 4.85

Median expressionⁱ : N/A

Median follow up timeⁱ : N/A

P scoreⁱ N/A

3-year survival highⁱ N/A

3-year survival lowⁱ N/A

TCGA RNA samplesⁱ

Average TPM

7.7

Number of samples

Samples

Sample	Description	TPM
AK005	N, NA, stage:NA, dead, 240 days	18.3
AK185	N, NA, stage:NA, alive, 330 days	14.4
AK188	N, NA, stage:NA, alive, 420 days	14.3
AK076	N, NA, stage:NA, alive, 660 days	14.2
AK231	N, NA, stage:NA, dead, 240 days	13.8
AK213	N, NA, stage:NA, alive, 2010 days	13.2
AK139	N, NA, stage:NA, dead, 270 days	13.1
AK066	N, NA, stage:NA, alive, 960 days	13.0
AK030	N, NA, stage:NA, dead, 120 days	12.1
AK134	N, NA, stage:NA, dead, 360 days	11.7
AK133	N, NA, stage:NA, dead, 360 days	11.3
AK195	N, NA, stage:NA, dead, 390 days	10.7
AK227	N, NA, stage:NA, alive, 300 days	10.5
AK055	N, NA, stage:NA, dead, 240 days	10.2
AK103	N, NA, stage:NA, alive, 1320 days	10.1
AK015	N, NA, stage:NA, alive, 720 days	9.7
AK124	N, NA, stage:NA, alive, 1920 days	9.7
AK068	N, NA, stage:NA, alive, 360 days	9.6
AK153	N, NA, stage:NA, dead, 240 days	9.3
AK158	N, NA, stage:NA, dead, 360 days	8.7
AK167	N, NA, stage:NA, dead, 180 days	8.6
AK165	N, NA, stage:NA, alive, 360 days	8.5
AK102	N, NA, stage:NA, alive, 1740 days	8.3
AK041	N, NA, stage:NA, alive, 810 days	8.1
AK218	N, NA, stage:NA, dead, 180 days	7.9
AK079	N, NA, stage:NA, dead, 210 days	7.8
AK199	N, NA, stage:NA, alive, 1860 days	7.5
AK043	N, NA, stage:NA, alive, 660 days	7.5
AK071	N, NA, stage:NA, dead, 540 days	7.3
AK117	N, NA, stage:NA, dead, 210 days	7.1
AK088	N, NA, stage:NA, dead, 360 days	7.0
AK091	N, NA, stage:NA, dead, 210 days	6.9
AK226	N, NA, stage:NA, dead, 360 days	6.9
AK183	N, NA, stage:NA, alive, 360 days	6.4
AK149	N, NA, stage:NA, dead, 420 days	6.4
AK098	N, NA, stage:NA, dead, 660 days	6.3
AK099	N, NA, stage:NA, dead, 420 days	6.2
AK049	N, NA, stage:NA, dead, 180 days	5.9
AK074	N, NA, stage:NA, alive, 300 days	5.8
AK003	N, NA, stage:NA, dead, 600 days	5.4
AK236	N, NA, stage:NA, dead, 360 days	5.4
AK100	N, NA, stage:NA, alive, 960 days	5.2
AK216	N, NA, stage:NA, dead, 360 days	4.9
AK006	N, NA, stage:NA, dead, 360 days	4.9
AK178	N, NA, stage:NA, dead, 240 days	4.8
AK081	N, NA, stage:NA, dead, 180 days	4.8
AK173	N, NA, stage:NA, dead, 180 days	4.7
AK085	N, NA, stage:NA, alive, 660 days	4.5
AK142	N, NA, stage:NA, alive, 90 days	4.0
AK053	N, NA, stage:NA, dead, 300 days	3.8
AK035	N, NA, stage:NA, dead, 210 days	3.8
AK123	N, NA, stage:NA, dead, 180 days	3.5
AK089	N, NA, stage:NA, dead, 330 days	3.5
AK072	N, NA, stage:NA, dead, 150 days	2.2
AK002	N, NA, stage:NA, dead, 570 days	2.1
AK051	N, NA, stage:NA, dead, 360 days	2.0
AK205	N, NA, stage:NA, dead, 120 days	1.8
AK156	N, NA, stage:NA, dead, 330 days	1.3
Show allShow less

GLIOBLASTOMA MULTIFORME - Protein relative expression (CPTAC)

Number of samples

110

Samples

Sample ID	Sample type	nRPX
CPT0196850003	Tumor	2.1
CPT0190240004	Tumor	2.1
CPT0218670003	Tumor	1.7
CPT0204330003	Normal	1.3
CPT0204360003	Normal	1.3
CPT0204350003	Normal	1.2
CPT0208980003	Tumor	1.1
CPT0204370003	Normal	1.1
CPT0204390003	Normal	1.0
CPT0190360004	Tumor	1.0
CPT0224330003	Tumor	0.9
CPT0201710003	Tumor	0.9
CPT0205890003	Tumor	0.8
CPT0204380003	Normal	0.8
CPT0182580003	Tumor	0.8
CPT0209440003	Tumor	0.7
CPT0204410003	Normal	0.6
CPT0204340003	Normal	0.6
CPT0092440003	Tumor	0.6
CPT0104220003	Tumor	0.6
CPT0125510003	Tumor	0.5
CPT0189460003	Tumor	0.5
CPT0225760003	Tumor	0.5
CPT0217880003	Tumor	0.4
CPT0206330003	Tumor	0.4
CPT0162140003	Tumor	0.4
CPT0204400003	Normal	0.4
CPT0189250003	Tumor	0.3
CPT0168720003	Tumor	0.3
CPT0087730003	Tumor	0.3
CPT0221180003	Tumor	0.3
CPT0204420003	Normal	0.2
CPT0206450003	Tumor	0.2
CPT0168480003	Tumor	0.2
CPT0228220003	Tumor	0.1
CPT0168590003	Tumor	0.1
CPT0199770003	Tumor	0.1
CPT0167750004	Tumor	0.1
CPT0218330004	Tumor	0.0
CPT0218960004	Tumor	0.0
CPT0087570003	Tumor	0.0
CPT0206880003	Tumor	-0.1
CPT0089150003	Tumor	-0.1
CPT0162020003	Tumor	-0.1
CPT0217100003	Tumor	-0.1
CPT0205670004	Tumor	-0.1
CPT0219080004	Tumor	-0.1
CPT0189750004	Tumor	-0.2
CPT0125220003	Tumor	-0.2
CPT0182550003	Tumor	-0.2
CPT0218890004	Tumor	-0.2
CPT0087680003	Tumor	-0.2
CPT0207030003	Tumor	-0.2
CPT0168270003	Tumor	-0.3
CPT0093590003	Tumor	-0.3
CPT0189650004	Tumor	-0.3
CPT0168380003	Tumor	-0.3
CPT0167860004	Tumor	-0.3
CPT0167970003	Tumor	-0.3
CPT0175060003	Tumor	-0.4
CPT0217060003	Tumor	-0.4
CPT0186100003	Tumor	-0.4
CPT0189850004	Tumor	-0.5
CPT0206000004	Tumor	-0.5
CPT0104330003	Tumor	-0.5
CPT0093550003	Tumor	-0.5
CPT0079790003	Tumor	-0.5
CPT0217190003	Tumor	-0.6
CPT0002410011	Tumor	-0.6
CPT0093450003	Tumor	-0.6
CPT0167530003	Tumor	-0.6
CPT0189570004	Tumor	-0.6
CPT0207090003	Tumor	-0.7
CPT0182500003	Tumor	-0.7
CPT0206780003	Tumor	-0.7
CPT0205570003	Tumor	-0.7
CPT0224600003	Tumor	-0.7
CPT0167640003	Tumor	-0.7
CPT0205450004	Tumor	-0.7
CPT0127480003	Tumor	-0.7
CPT0224540004	Tumor	-0.8
CPT0216920008	Tumor	-0.8
CPT0071100003	Tumor	-0.8
CPT0161730003	Tumor	-0.8
CPT0224390004	Tumor	-0.8
CPT0218770003	Tumor	-0.8
CPT0206670004	Tumor	-0.8
CPT0225730003	Tumor	-0.8
CPT0218690004	Tumor	-0.8
CPT0093510003	Tumor	-0.8
CPT0127420003	Tumor	-0.9
CPT0093360003	Tumor	-0.9
CPT0217710008	Tumor	-0.9
CPT0064890003	Tumor	-1.0
CPT0162100003	Tumor	-1.0
CPT0206230003	Tumor	-1.0
CPT0123530003	Tumor	-1.1
CPT0078580003	Tumor	-1.1
CPT0168830003	Tumor	-1.1
CPT0087950003	Tumor	-1.1
CPT0205780003	Tumor	-1.1
CPT0064650003	Tumor	-1.1
CPT0218830004	Tumor	-1.2
CPT0217430008	Tumor	-1.3
CPT0206110003	Tumor	-1.4
CPT0168080003	Tumor	-1.4
CPT0217000004	Tumor	-1.6
CPT0125570003	Tumor	-1.6
CPT0171580008	Tumor	-1.7
CPT0206560003	Tumor	-1.8
Show allShow less

GLIOMA - Protein expressionⁱ

Pending cancer tissue analysis